Search Within


Applied Filters:
Showing 1-15 of 15 results for "B3773" within Papers
Structure and function of immunoglobulins.
Schroeder Jr H W and Cavacini L
The Journal of Allergy and Clinical Immunology, 125(2), S41-S52 (2010)
Gunnveig Grodeland et al.
Journal of immunology (Baltimore, Md. : 1950), 191(6), 3221-3231 (2013-08-21)
New influenza A viruses with pandemic potential periodically emerge due to viral genomic reassortment. In the face of pandemic threats, production of conventional egg-based vaccines is time consuming and of limited capacity. We have developed in this study a novel
IgG subclasses and allotypes: from structure to effector functions
Vidarsson G, et al.
Frontiers in Immunology, 5(2), 520-520 (2014)
Alan Warnes et al.
Methods in molecular medicine, 94, 373-391 (2004-02-13)
Analysis of the humoral immune response to infectious diseases has played, and will to continue to play, a key role in their diagnosis and immune surveillance. Although rapid genome detection methodologies, such as PCR, are beginning to replace immune assays
S Ortega-Vargas et al.
Vaccine, 37(24), 3234-3240 (2019-05-01)
Leucine aminopeptidase (FhLAP) and cathepsin L1 (FhCL1) of Fasciola hepatica play a critical role in parasite feeding, migration through host tissue, and immune evasion. These antigens have been tested for immune protection as single components with variable degrees of success.
A Warnes et al.
Methods in molecular medicine, 13, 201-211 (1998-01-01)
The introduction of genetic engineering techniques has allowed the controlled and efficient production of recombinant proteins. This presents scientists with the opportunity to use a wide range of proteins for a number purposes, previously unavailable because of problems relating to
The complete map of the Ig heavy chain constant gene region reveals evidence for seven IgG isotypes and for IgD in the horse
Wagner B, et al.
Journal of Immunology, 173(5), 3230-3242 (2004)
Marta Baranowska et al.
Vaccine, 33(49), 6988-6996 (2015-09-22)
Vaccination is at present the most efficient way of preventing influenza infections. Currently used inactivated influenza vaccines can induce virus-neutralizing antibodies that are protective against a particular influenza strain, but hamper the induction of cross-protective T-cell responses to later infections.
Divya Thiagarajan et al.
Journal of immunology (Baltimore, Md. : 1950), 205(8), 2109-2116 (2020-09-06)
Abs against phosphorylcholine (anti-PC) and Abs against malondialdehyde (anti-MDA) may be protective in chronic inflammation, like atherosclerosis and cardiovascular disease. It is not known how they develop early in life. Ab titers were measured using ELISA in healthy women (n
Gunnveig Grødeland et al.
PloS one, 8(11), e80008-e80008 (2013-11-19)
Different diseases require different immune responses for efficient protection. Thus, prophylactic vaccines should prime the immune system for the particular type of response needed for protection against a given infectious agent. We have here tested fusion DNA vaccines which encode
María Eugenia Toledo-Romani et al.
Med (New York, N.Y.) (2022-08-24)
SOBERANA 02 has been evaluated in phase I and IIa studies comparing homologous versus heterologous schedule (this one, including SOBERANA Plus). Here, we report results of immunogenicity, safety, and reactogenicity of SOBERANA 02 in a two- or three-dose heterologous scheme
Intracellular cytokines may model immunoregulation of abacavir hypersensitivity in HIV-infected subjects.
King D, et al.
The Journal of Allergy and Clinical Immunology, 115(5), 1081-1087 (2005)
C Whitney et al.
Infection and immunity, 60(6), 2194-2200 (1992-06-01)
Porphyromonas gingivalis is a suspected pathogen in rapidly progressive periodontitis (RPP). We have determined the anti-P. gingivalis serum immunoglobulin G (IgG) isotype response and avidity and the subclass titer distributions for 30 RPP patients and 30 age-, sex-, and race-matched
S Hashira et al.
Pediatrics international : official journal of the Japan Pediatric Society, 42(4), 337-342 (2000-09-15)
Maternal immunoglobulin G (IgG), transferred across the placenta to the fetus during intrauterine life, is an important component of the neonatal immunological defence mechanisms against infection. There is controversy with respect to differences in placental transfer of the different IgG
Molecular properties of human IgG subclasses and their implications for designing therapeutic monoclonal antibodies against infectious diseases.
Irani V, et al.
Molecular Immunology, 67(2), 171-182 (2015)
Page 1 of 1